Behavioral Addictions in the Context of the DSM-5 and ICD-10: Neurobiological and Clinical Considerations

This event is a part of the Office of Global and Lifelong Learning's Spring 2015 Seminar Series on Behavioral Disorders.
February 13, 2015
9:00 am - 12:00 pm
NYU Silver School of Social Work
1 Washington Square North, Parlor
This event will include a light breakfast.


The extent to which non-substance-related conditions may be considered as addictions has been debated.  Based on epidemiological, clinical, phenomenological, genetic, neurobiological and other data, pathological gambling (now gambling disorder) has been reclassified in DSM-5 together with substance-use disorders, providing additional support for the concept of non-substance or behavioral addictions.  The presentation will review current considerations on the topic of behavioral addictions, including consideration of gambling, eating, Internet use and other behaviors with the potential for addictive engagement.  A focus on gambling disorder will include how neurobiological information may be used to understand the disorder and link to treatment strategies.  Techniques for identifying individuals with gambling disorder and intervening will be discussed.


Marc N. Potenza, PhD, MD, Professor of Psychiatry, in the Child Study Center and of Neurobiology; Director, Center of Excellence in Gambling Research; Director, Yale Program for Research on Impulsivity and Impulse Control Disorders; Director, Women and Addictive Disorders, Women's Health Research at Yale
Dr. Potenza is a board-certified psychiatrist with sub-specialty training and certification in addiction psychiatry. He has trained at Yale University receiving a combined BS/MS with Honors in Molecular Biochemistry and Biophysics and a PhD in Cell Biology, the latter concurrent with the MD through the Medical Scientist Training Program. He completed internship, psychiatric residency and addiction psychiatry fellowship training at Yale. Currently, he is a Professor of Psychiatry, Child Study and Neurobiology at the Yale University School of Medicine where he is Director of the Problem Gambling Clinic, the Center of Excellence in Gambling Research, and the Women and Addictive Disorders Core of Women's Health Research at Yale, and Director of Neuroimaging for the VISN1 MIRECC of the VA Connecticut Healthcare System. He is on the editorial boards of eight journals and has received multiple national and international awards for excellence in research and clinical care. He has consulted to the Substance Abuse and Mental Health Services Administration, National Registry of Effective Programs, National Institutes of Health, American Psychiatric Association and World Health Organization on matters of addiction.
Research Areas:
A. Pathological gambling
B. Impulse control disorders
C. Substance abuse
D. Addiction
E. Gender differences
Selected Publications:
Jastreboff AM, Potenza MN, Lacadie C, Hong K, Sherwin R, Sinha R (in press) Body mass index, metabolic factors and striatal activation during stressful and neutral/relaxing states: an fMRI study. Neuropsychopharmacol
Desai RA, Krishnan-Sarin S, Cavallo DA, Potenza MN (in press) Gender differences in the clinical correlates of problematic video game playing in high school students. Pediatrics
Barry DT, Stefanovics EA, Desai RA, Potenza MN (in press) Gambling Problem Severity and Psychiatric Disorders among Hispanic and White Adults: Findings from a Nationally Representative Sample. J Psychiatry Res
Liu TC, Desai RA, Krishnan-Sarin S, Cavallo DA, Potenza MN (in press) Problematic Internet Use and Health in Adolescents: Data from a High School Survey in Connecticut. J Clin Psychiatry
Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW (2010) A Multi-Center, Double-Blind, Placebo-Controlled Study of the Opioid Antagonist Nalmefene in the Treatment of Pathological Gambling. Brit J Psychiatry 197:330-331
Xu J, DeVito EE, Worhunsky PD, Carroll KM, Rounsaville BJ, Potenza MN (2010) White Matter Integrity is Associated with Treatment Outcome Measures in Cocaine Dependence. Neuropsychopharmacol 35:1541-1549.
Ph.D., Yale University, 1993
M.D., Yale University School of Medicine, 1994